Evaluation of a machine learning tool for the early identification of patients with undiagnosed psoriatic arthritis – A retrospective population-based study

Alinaghi, 2019, Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies, J. Am. Acad. Dermatol., 80, 251, 10.1016/j.jaad.2018.06.027 Wilson, 2009, Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study, Arthritis Rheum., 61, 233, 10.1002/art.24172 Love, 2012, Obesity and the risk of psoriatic arthritis: a population-based study, Ann. Rheum. Dis., 71, 1273, 10.1136/annrheumdis-2012-201299 Eder, 2016, The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study, Arthritis Rheum., 68, 915, 10.1002/art.39494 Prey, 2010, Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature, J. Eur. Acad. Dermatol. Venereol., 24, 31, 10.1111/j.1468-3083.2009.03565.x Christophers, 2010, The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics, J. Eur. Acad. Dermatol. Venereol., 24, 548, 10.1111/j.1468-3083.2009.03463.x Gelfand, 2005, Epidemiology of psoriatic arthritis in the population of the United States, J. Am. Acad. Dermatol., 3, 573 Karmacharya, 2021, The epidemiology of psoriatic arthritis: a literature review, Best Pract. Res. Clin. Rheumatol., 35, 10.1016/j.berh.2021.101692 Eder, 2018, The epidemiology of psoriatic arthritis in Israel - a population-based study, Arthritis Res. Ther., 20, 3, 10.1186/s13075-017-1497-4 Villani, 2015, Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis, J. Am. Acad. Dermatol., 73, 242, 10.1016/j.jaad.2015.05.001 Spelman, 2015, Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice, J. Eur. Acad. Dermatol. Venereol., 29, 2184, 10.1111/jdv.13210 Karmacharya, 2021, Diagnostic delay in psoriatic arthritis: a population-based study, J. Rheumatol., 48, 1410, 10.3899/jrheum.201199 Haroon, 2015, Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis, Ann. Rheum. Dis., 74, 1045, 10.1136/annrheumdis-2013-204858 Tillett, 2013, Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis, Ann. Rheum. Dis., 72, 1358, 10.1136/annrheumdis-2012-202608 Zachariae, 2003, Prevalence of joint disease in patients with psoriasis: implications for therapy, Am. J. Clin. Dermatol., 4, 441, 10.2165/00128071-200304070-00001 Mease, 2005, Diagnosis and treatment of psoriatic arthritis, J. Am. Acad. Dermatol., 52, 1, 10.1016/j.jaad.2004.06.013 Brockbank, 2002, Diagnosis and management of psoriatic arthritis, Drugs, 62, 2447, 10.2165/00003495-200262170-00004 Gladman, 2000, Psoriatic arthritis, Expet Opin. Invest. Drugs, 9, 1511, 10.1517/13543784.9.7.1511 Gelfand, 2006, Risk of myocardial infarction in patients with psoriasis, JAMA, 296, 1735, 10.1001/jama.296.14.1735 Shapiro, 2012, Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis, J. Am. Acad. Dermatol., 66, 252, 10.1016/j.jaad.2010.11.046 Gladman, 1987, Psoriatic arthritis (PSA) – an analysis of 220 patients, Q. J. Med., 62, 127 Dominguez, 2010, Development of screening tools to identify psoriatic arthritis, Curr. Rheumatol. Rep., 12, 295, 10.1007/s11926-010-0113-2 Peloso, 1997, The psoriasis and arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis, Arthritis Rheum., 40, S64 Alenius, 2002, Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire, J. Rheumatol., 29, 2577 Qureshi, 2008, Psoriatic arthritis screening tools, J. Rheumatol., 35, 1423 Ibrahim, 2009, Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire, Clin. Exp. Rheumatol., 27, 469 Tom, 2015, Validation of the toronto psoriatic arthritis screen version 2 (ToPAS 2), J. Rheumatol., 42, 841, 10.3899/jrheum.140857 Urruticoechea-Arana, 2021, Psoriatic arthritis screening: a systematic literature review and experts' recommendations, PLoS One, 16, 10.1371/journal.pone.0248571 Audureau, 2018, Psoriatic arthritis screening by the dermatologist: development and first validation of the ’PURE-4 scale, J. Eur. Acad. Dermatol. Venereol., 32, 1950, 10.1111/jdv.14861 Mayzel Asgari, 2013, Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009, Pharmacoepidemiol. Drug Saf., 22, 842, 10.1002/pds.3447 Lundberg Lee, 2020, Validation of claims-based algorithms for psoriatic arthritis, Pharmacoepidemiol. Drug Saf., 29, 404, 10.1002/pds.4950 Eder, 2020, Arthritis patients in ontario administrative data: a population-based study from 1991 to 2015, J. Rheumatol., 47, 1644, 10.3899/jrheum.190659 Dobson-Belaire, 2018, Identifying psoriasis and psoriatic arthritis patients in retrospective databases when diagnosis codes are not available: a validation study comparing medication/prescriber visit-based algorithms with diagnosis codes, Value Health, 21, 110, 10.1016/j.jval.2017.06.012 Strober, 2008, Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis, Br. J. Dermatol., 59, 322, 10.1111/j.1365-2133.2008.08628.x Fitzgerald, 2012, Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting, J. Rheumatol., 39, 427, 10.3899/jrheum.111241 Pakchotanon, 2020, Liver abnormalities in patients with psoriatic arthritis, J. Rheumatol., 47, 847, 10.3899/jrheum.181312